MK-0354

MK-0354 Uses, Dosage, Side Effects, Food Interaction and all others data.

MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.

Table Of contents

• MK-0354
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	MK-0354
Generic	MK-0354
Type
Formula	C7H8N6
Weight	Average: 176.183 Monoisotopic: 176.081044282
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in atherosclerosis.

Innovators Monograph

You find simplified version here MK-0354